Article
Signal peptide mimicry primes Sec61 for client-selective inhibition
11 May 2023
Abstract excerpt
Preventing the biogenesis of disease-relevant proteins is an attractive therapeutic strategy, but attempts to target essential protein biogenesis factors have been hampered by excessive toxicity. Here we describe KZR-8445, a cyclic depsipeptide that targets the Sec61 translocon and selectively disrupts secretory and membrane protein biogenesis in a signal peptide-dependent manner. KZR-8445 potently inhibits the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
